Skip to main content
Log in

This letter was forwarded to Drs. E.E Müller, F. Camanni and A.R. Genazzani whose reply follows

  • Letter to the Editor
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Pontiroli A.E., Loda G., Roggia A., Scagliola P., Falsetti L Benserazide and nomifensine in the diagnosis of prolactin-secreting pituitary adenomas. Acta Endocrinol. (Kbh.) 101: 171, 1982.

    CAS  Google Scholar 

  2. Iodice M., Lombardi G., Tommaselli A., Rossi R., Annunziato L, Minozzi M. Agreement of prolactin response to Cimetidine and nomifensine in patients with prolactin-secreting tumors and idiopathic hyperprolactinemia. Neuroendocrinology 35: 333, 1982.

    Article  CAS  PubMed  Google Scholar 

  3. Minuto F., Barbarino A., Baviera G., Mazzocchi G., De Marinis L, Leonardi R., Bernasconi D., Menini E., Maira G., Anile C., Giusti M., Giordano G. Multicentric experience on the acute effect of nomifensine in hyperprolactinemic women. J. Endocrinol. Invest. 7: 137, 1984.

    Article  CAS  PubMed  Google Scholar 

  4. Camanni F., Genazzani A.R., Massara F, De Leo V., Molinatti G.M., Müller E.E. Prolactin responsiveness to nomifensine in patients with hyperprolactinemia of tumorous or uncertain etiology. J. Clin. Endocrinol. Metab. 51: 650, 1980.

    Article  CAS  PubMed  Google Scholar 

  5. Bansal S., Lee L.A., Woolf P.D. Abnormal prolactin responsivity to dopaminergic suppression in hyperprolactinemic patients. Am. J. Med. 7: 961, 1981.

    Article  Google Scholar 

  6. Serri O., Kuchel O., Bun N.T., Somma M. Differential effects of a low dose dopamine infusion on prolactin secretion in normal and hyperprolactinemic subjects. J. Clin. Endocrinol. Metab. 56: 256, 1983.

    Article  Google Scholar 

  7. Ho K.Y., Smythe G.A., Duncan M., Lazarus M. Dopamine infusion studies in patients with pathological hyperprolactinemia: evidence for normal prolactin sup-pressibility but abnormal dopamine metabolism. J. Clin. Endocrinol. Metab. 58: 128, 1984.

    Article  CAS  PubMed  Google Scholar 

  8. Martin M.C., Weiner R.I., Monroe S.E., Roberts J.M., Licko V., Jaffe R.B. Prolactin-secreting adenomas in women. VII. Dopamine regulation of prolactin secretion. J. Clin. Endocrinol. Metab. 59: 485, 1984.

    Article  CAS  PubMed  Google Scholar 

  9. Cocchi D., Casanueva F., Locatelli V., Penalva A., Novelli A., Bestetti G., Rossi G.L, Müller E.E. Pathophysiological aspects of prolactinomas. In: G.M. Molinatti (Ed.), A Clinical problem: Microprolacti-noma. Excerpta Medica, Amsterdam, 1982, p. 1.

    Google Scholar 

  10. Penalva A., Novelli A., Pareti M., Locatelli V., Müller E.E., Cocchi D. Hypothalamic neurotransmitter function in experimentally induced hyperprolactinemia. Brain Res. 1984.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Müller, E.E., Camanni, F. & Genazzani, A.R. This letter was forwarded to Drs. E.E Müller, F. Camanni and A.R. Genazzani whose reply follows. J Endocrinol Invest 8, 183–184 (1985). https://doi.org/10.1007/BF03350680

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03350680

Keywords

Navigation